These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells. Riganti L; Matteoni C; Di Angelantonio S; Nistri A; Gaimarri A; Sparatore F; Canu-Boido C; Clementi F; Gotti C Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122 [TBL] [Abstract][Full Text] [Related]
11. Methadone is a non-competitive antagonist at the α4β2 and α3* nicotinic acetylcholine receptors and an agonist at the α7 nicotinic acetylcholine receptor. Talka R; Salminen O; Tuominen RK Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):321-8. PubMed ID: 25196810 [TBL] [Abstract][Full Text] [Related]
12. Desensitization of neuronal nicotinic receptors of human neuroblastoma SH-SY5Y cells during short or long exposure to nicotine. Sokolova E; Matteoni C; Nistri A Br J Pharmacol; 2005 Dec; 146(8):1087-95. PubMed ID: 16230999 [TBL] [Abstract][Full Text] [Related]
13. AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats. Toll L; Zaveri NT; Polgar WE; Jiang F; Khroyan TV; Zhou W; Xie XS; Stauber GB; Costello MR; Leslie FM Neuropsychopharmacology; 2012 May; 37(6):1367-76. PubMed ID: 22278092 [TBL] [Abstract][Full Text] [Related]
14. Nicotinic acetylcholine receptors in human neuroblastoma (SH-SY5Y) cells. Gould J; Reeve HL; Vaughan PF; Peers C Neurosci Lett; 1992 Oct; 145(2):201-4. PubMed ID: 1465217 [TBL] [Abstract][Full Text] [Related]
15. Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptors. van Hout M; Klein J; Ahring PK; Brown DT; Thaneshwaran S; Dos Santos AB; Jensen AA; Kohlmeier KA; Christophersen P; Dyhring T Biochem Pharmacol; 2020 Apr; 174():113788. PubMed ID: 31887290 [TBL] [Abstract][Full Text] [Related]
16. Functional properties of homomeric, human alpha 7-nicotinic acetylcholine receptors heterologously expressed in the SH-EP1 human epithelial cell line. Zhao L; Kuo YP; George AA; Peng JH; Purandare MS; Schroeder KM; Lukas RJ; Wu J J Pharmacol Exp Ther; 2003 Jun; 305(3):1132-41. PubMed ID: 12626641 [TBL] [Abstract][Full Text] [Related]
17. 2-Fluoro-3-(4-nitro-phenyl)deschloroepibatidine is a novel potent competitive antagonist of human neuronal alpha4beta2 nAChRs. Abdrakhmanova GR; Damaj MI; Carroll FI; Martin BR Mol Pharmacol; 2006 Jun; 69(6):1945-52. PubMed ID: 16505153 [TBL] [Abstract][Full Text] [Related]
18. Iptakalim inhibits nicotinic acetylcholine receptor-mediated currents in dopamine neurons acutely dissociated from rat substantia nigra pars compacta. Hu J; DeChon J; Yan KC; Liu Q; Hu G; Wu J Neurosci Lett; 2006 Jul; 403(1-2):57-62. PubMed ID: 16730119 [TBL] [Abstract][Full Text] [Related]
19. Functional characterization of AT-1001, an α3β4 nicotinic acetylcholine receptor ligand, at human α3β4 and α4β2 nAChR. Zaveri NT; Bertrand S; Yasuda D; Bertrand D Nicotine Tob Res; 2015 Mar; 17(3):361-7. PubMed ID: 25180076 [TBL] [Abstract][Full Text] [Related]
20. High affinity α3β4 nicotinic acetylcholine receptor ligands AT-1001 and AT-1012 attenuate cocaine-induced conditioned place preference and behavioral sensitization in mice. Khroyan TV; Yasuda D; Toll L; Polgar WE; Zaveri NT Biochem Pharmacol; 2015 Oct; 97(4):531-541. PubMed ID: 26256075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]